연구용 항체 시장 : 시장 규모, 점유율 및 동향 분석(제품별, 특이성별, 기술별, 공급원별, 용도별, 최종 용도별, 지역별), 부문별 예측(2025-2033년)

Research Antibodies Market Summary

The global research antibodies market size was estimated at USD 1.79 billion in 2024 and is projected to reach USD 3.91 billion by 2033, growing at a CAGR of 9.15% from 2025 to 2033. The market for research antibodies is expanding rapidly due to the rising incidence of infectious and chronic illnesses, improvements in proteomics and genomics research, and the growing use of personalized medicine.

Global Research Antibodies Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global research antibodies market report based on product, specificity, technology, source, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Primary Antibodies
• Secondary Antibodies
• Specificity Outlook (Revenue, USD Million, 2021 - 2033)
• Monoclonal Antibodies
• Polyclonal Antibodies
• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• Immunohistochemistry
• Immunofluorescence
• Western Blotting
• Flow Cytometry
• Immunoprecipitation
• ELISA
• Others
• Source Outlook (Revenue, USD Million, 2021 - 2033)
• Mouse
• Rabbit
• Goat
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Infectious Diseases
• Immunology
• Oncology
• Stem Cells
• Neurobiology
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Academic & Research Institutes
• Contract Research Organizations
• Pharmaceutical & Biotechnology Companies
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
  • Singapore
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product Segment
  • 1.1.2. Specificity Segment
  • 1.1.3. Technology Segment
  • 1.1.4. Source Segment
  • 1.1.5. Application Segment
  • 1.1.6. End Use Segment
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List Of Secondary Sources
• 1.8. List Of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising burden of chronic and infectious diseases
    • 3.2.1.2. Expansion of life sciences and biomedical research
  • 3.2.2. Market Restraint And Challenges Analysis
    • 3.2.2.1. Uncertain government regulations
    • 3.2.2.2. Quality concerns associated with research antibodies and the time- & cost-intensive process of antibody development
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis

Chapter 4. Product Business Analysis

• 4.1. Product Segment Dashboard
• 4.2. Research Antibodies Market Product Movement Analysis
• 4.3. Research Antibodies Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Primary Antibodies
  • 4.4.1. Primary Antibodies Market, 2021 - 2033 (USD Million)
• 4.5. Secondary Antibodies
  • 4.5.1. Secondary Antibodies Market, 2021 - 2033 (USD Million)

Chapter 5. Specificity Business Analysis

• 5.1. Specificity Segment Dashboard
• 5.2. Research Antibodies Market Specificity Movement Analysis
• 5.3. Research Antibodies Market Size & Trend Analysis, by Specificity, 2021 to 2033 (USD Million)
• 5.4. Monoclonal Antibodies
  • 5.4.1. Monoclonal Antibodies Market, 2021 - 2033 (USD Million)
• 5.5. Polyclonal Antibodies
  • 5.5.1. Polyclonal Antibodies Market, 2021 - 2033 (USD Million)

Chapter 6. Technology Business Analysis

• 6.1. Technology Segment Dashboard
• 6.2. Research Antibodies Market Technology Movement Analysis
• 6.3. Research Antibodies Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
• 6.4. Immunohistochemistry
  • 6.4.1. Immunohistochemistry Market, 2021 - 2033 (USD Million)
• 6.5. Immunofluorescence
  • 6.5.1. Immunofluorescence Market, 2021 - 2033 (USD Million)
• 6.6. Western Blotting
  • 6.6.1. Western Blotting Market, 2021 - 2033 (USD Million)
• 6.7. Flow Cytometry
  • 6.7.1. Flow Cytometry Market, 2021 - 2033 (USD Million)
• 6.8. Immunoprecipitation
  • 6.8.1. Immunoprecipitation Market, 2021 - 2033 (USD Million)
• 6.9. ELISA
  • 6.9.1. ELISA Market, 2021 - 2033 (USD Million)
• 6.10. Others
  • 6.10.1. Other Technologies Market, 2021 - 2033 (USD Million)

Chapter 7. Source Business Analysis

• 7.1. Source Segment Dashboard
• 7.2. Research Antibodies Market Source Movement Analysis
• 7.3. Research Antibodies Market Size & Trend Analysis, by Source, 2021 to 2033 (USD Million)
• 7.4. Mouse
  • 7.4.1. Mouse Market, 2021 - 2033 (USD Million)
• 7.5. Rabbit
  • 7.5.1. Rabbit Market, 2021 - 2033 (USD Million)
• 7.6. Goat
  • 7.6.1. Goat Market, 2021 - 2033 (USD Million)
• 7.7. Others
  • 7.7.1. Other Sources Market, 2021 - 2033 (USD Million)

Chapter 8. Application Business Analysis

• 8.1. Application Segment Dashboard
• 8.2. Research Antibodies Market Application Movement Analysis
• 8.3. Research Antibodies Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 8.4. Infectious Diseases
  • 8.4.1. Infectious Diseases Market, 2021 - 2033 (USD Million)
• 8.5. Immunology
  • 8.5.1. Immunology Market, 2021 - 2033 (USD Million)
• 8.6. Oncology
  • 8.6.1. Oncology Market, 2021 - 2033 (USD Million)
• 8.7. Stem Cells
  • 8.7.1. Stem Cells Market, 2021 - 2033 (USD Million)
• 8.8. Neurobiology
  • 8.8.1. Neurobiology Market, 2021 - 2033 (USD Million)
• 8.9. Others
  • 8.9.1. Other Applications Market, 2021 - 2033 (USD Million)

Chapter 9. End Use Business Analysis

• 9.1. End Use Segment Dashboard
• 9.2. Research Antibodies Market End Use Movement Analysis
• 9.3. Research Antibodies Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 9.4. Academic & Research Institutes
  • 9.4.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)
• 9.5. Contract Research Organizations
  • 9.5.1. Contract Research Organizations Market, 2021 - 2033 (USD Million)
• 9.6. Pharmaceutical & Biotechnology Companies
  • 9.6.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Million)

Chapter 10. Regional Business Analysis

• 10.1. Research Antibodies Market Share By Region, 2024 & 2033
• 10.2. North America
  • 10.2.1. North America Research Antibodies Market, 2021 - 2033 (USD Million)
  • 10.2.2. U.S.
    • 10.2.2.1. Key Country Dynamics
    • 10.2.2.2. Regulatory Framework
    • 10.2.2.3. Competitive Scenario
    • 10.2.2.4. U.S. Research Antibodies Market, 2021 - 2033 (USD Million)
  • 10.2.3. Canada
    • 10.2.3.1. Key Country Dynamics
    • 10.2.3.2. Regulatory Framework
    • 10.2.3.3. Competitive Scenario
    • 10.2.3.4. Canada Research Antibodies Market, 2021 - 2033 (USD Million)
  • 10.2.4. Mexico
    • 10.2.4.1. Key Country Dynamics
    • 10.2.4.2. Regulatory Framework
    • 10.2.4.3. Competitive Scenario
    • 10.2.4.4. Mexico Research Antibodies Market, 2021 - 2033 (USD Million)
• 10.3. Europe
  • 10.3.1. Europe Research Antibodies Market, 2021 - 2033 (USD Million)
  • 10.3.2. UK
    • 10.3.2.1. Key Country Dynamics
    • 10.3.2.2. Regulatory Framework
    • 10.3.2.3. Competitive Scenario
    • 10.3.2.4. UK Research Antibodies Market, 2021 - 2033 (USD Million)
  • 10.3.3. Germany
    • 10.3.3.1. Key Country Dynamics
    • 10.3.3.2. Regulatory Framework
    • 10.3.3.3. Competitive Scenario
    • 10.3.3.4. Germany Research Antibodies Market, 2021 - 2033 (USD Million)
  • 10.3.4. France
    • 10.3.4.1. Key Country Dynamics
    • 10.3.4.2. Regulatory Framework
    • 10.3.4.3. Competitive Scenario
    • 10.3.4.4. France Research Antibodies Market, 2021 - 2033 (USD Million)
  • 10.3.5. Italy
    • 10.3.5.1. Key Country Dynamics
    • 10.3.5.2. Regulatory Framework
    • 10.3.5.3. Competitive Scenario
    • 10.3.5.4. Italy Research Antibodies Market, 2021 - 2033 (USD Million)
  • 10.3.6. Spain
    • 10.3.6.1. Key Country Dynamics
    • 10.3.6.2. Regulatory Framework
    • 10.3.6.3. Competitive Scenario
    • 10.3.6.4. Spain Research Antibodies Market, 2021 - 2033 (USD Million)
  • 10.3.7. Denmark
    • 10.3.7.1. Key Country Dynamics
    • 10.3.7.2. Regulatory Framework
    • 10.3.7.3. Competitive Scenario
    • 10.3.7.4. Denmark Research Antibodies Market, 2021 - 2033 (USD Million)
  • 10.3.8. Sweden
    • 10.3.8.1. Key Country Dynamics
    • 10.3.8.2. Regulatory Framework
    • 10.3.8.3. Competitive Scenario
    • 10.3.8.4. Sweden Research Antibodies Market, 2021 - 2033 (USD Million)
  • 10.3.9. Norway
    • 10.3.9.1. Key Country Dynamics
    • 10.3.9.2. Regulatory Framework
    • 10.3.9.3. Competitive Scenario
    • 10.3.9.4. Norway Research Antibodies Market, 2021 - 2033 (USD Million)
• 10.4. Asia Pacific
  • 10.4.1. Asia Pacific Research Antibodies Market, 2021 - 2033 (USD Million)
  • 10.4.2. Japan
    • 10.4.2.1. Key Country Dynamics
    • 10.4.2.2. Regulatory Framework
    • 10.4.2.3. Competitive Scenario
    • 10.4.2.4. Japan Research Antibodies Market, 2021 - 2033 (USD Million)
  • 10.4.3. China
    • 10.4.3.1. Key Country Dynamics
    • 10.4.3.2. Regulatory Framework
    • 10.4.3.3. Competitive Scenario
    • 10.4.3.4. China Research Antibodies Market, 2021 - 2033 (USD Million)
  • 10.4.4. India
    • 10.4.4.1. Key Country Dynamics
    • 10.4.4.2. Regulatory Framework
    • 10.4.4.3. Competitive Scenario
    • 10.4.4.4. India Research Antibodies Market, 2021 - 2033 (USD Million)
  • 10.4.5. Australia
    • 10.4.5.1. Key Country Dynamics
    • 10.4.5.2. Regulatory Framework
    • 10.4.5.3. Competitive Scenario
    • 10.4.5.4. Australia Research Antibodies Market, 2021 - 2033 (USD Million)
  • 10.4.6. Thailand
    • 10.4.6.1. Key Country Dynamics
    • 10.4.6.2. Regulatory Framework
    • 10.4.6.3. Competitive Scenario
    • 10.4.6.4. Thailand Research Antibodies Market, 2021 - 2033 (USD Million)
  • 10.4.7. South Korea
    • 10.4.7.1. Key Country Dynamics
    • 10.4.7.2. Regulatory Framework
    • 10.4.7.3. Competitive Scenario
    • 10.4.7.4. South Korea Research Antibodies Market, 2021 - 2033 (USD Million)
  • 10.4.8. Singapore
    • 10.4.8.1. Key Country Dynamics
    • 10.4.8.2. Regulatory Framework
    • 10.4.8.3. Competitive Scenario
    • 10.4.8.4. Singapore Research Antibodies Market, 2021 - 2033 (USD Million)
• 10.5. Latin America
  • 10.5.1. Latin America Research Antibodies Market, 2021 - 2033 (USD Million)
  • 10.5.2. Brazil
    • 10.5.2.1. Key Country Dynamics
    • 10.5.2.2. Regulatory Framework
    • 10.5.2.3. Competitive Scenario
    • 10.5.2.4. Brazil Research Antibodies Market, 2021 - 2033 (USD Million)
  • 10.5.3. Argentina
    • 10.5.3.1. Key Country Dynamics
    • 10.5.3.2. Regulatory Framework
    • 10.5.3.3. Competitive Scenario
    • 10.5.3.4. Argentina Research Antibodies Market, 2021 - 2033 (USD Million)
• 10.6. MEA
  • 10.6.1. MEA Research Antibodies Market, 2021 - 2033 (USD Million)
  • 10.6.2. South Africa
    • 10.6.2.1. Key Country Dynamics
    • 10.6.2.2. Regulatory Framework
    • 10.6.2.3. Competitive Scenario
    • 10.6.2.4. South Africa Research Antibodies Market, 2021 - 2033 (USD Million)
  • 10.6.3. Saudi Arabia
    • 10.6.3.1. Key Country Dynamics
    • 10.6.3.2. Regulatory Framework
    • 10.6.3.3. Competitive Scenario
    • 10.6.3.4. Saudi Arabia Research Antibodies Market, 2021 - 2033 (USD Million)
  • 10.6.4. UAE
    • 10.6.4.1. Key Country Dynamics
    • 10.6.4.2. Regulatory Framework
    • 10.6.4.3. Competitive Scenario
    • 10.6.4.4. UAE Research Antibodies Market, 2021 - 2033 (USD Million)
  • 10.6.5. Kuwait
    • 10.6.5.1. Key Country Dynamics
    • 10.6.5.2. Regulatory Framework
    • 10.6.5.3. Competitive Scenario
    • 10.6.5.4. Kuwait Research Antibodies Market, 2021 - 2033 (USD Million)

Chapter 11. Competitive Landscape

• 11.1. Company Categorization
• 11.2. Strategy Mapping
• 11.3. Company Market Position Analysis, 2024
• 11.4. Company Profiles/Listing
  • 11.4.1. Abcam Plc
    • 11.4.1.1. Overview
    • 11.4.1.2. Financial Performance
    • 11.4.1.3. Product Benchmarking
    • 11.4.1.4. Strategic Initiatives
  • 11.4.2. Merck KGaA
    • 11.4.2.1. Overview
    • 11.4.2.2. Financial Performance
    • 11.4.2.3. Product Benchmarking
    • 11.4.2.4. Strategic Initiatives
  • 11.4.3. Thermo Fisher Scientific, Inc.
    • 11.4.3.1. Overview
    • 11.4.3.2. Financial Performance
    • 11.4.3.3. Product Benchmarking
    • 11.4.3.4. Strategic Initiatives
  • 11.4.4. Cell Signaling Technology, Inc.
    • 11.4.4.1. Overview
    • 11.4.4.2. Financial Performance
    • 11.4.4.3. Product Benchmarking
    • 11.4.4.4. Strategic Initiatives
  • 11.4.5. Santa Cruz Biotechnology Inc.
    • 11.4.5.1. Overview
    • 11.4.5.2. Financial Performance
    • 11.4.5.3. Product Benchmarking
    • 11.4.5.4. Strategic Initiatives
  • 11.4.6. PerkinElmer, Inc.
    • 11.4.6.1. Overview
    • 11.4.6.2. Financial Performance
    • 11.4.6.3. Product Benchmarking
    • 11.4.6.4. Strategic Initiatives
  • 11.4.7. Becton, Dickinson and Company
    • 11.4.7.1. Overview
    • 11.4.7.2. Financial Performance
    • 11.4.7.3. Product Benchmarking
    • 11.4.7.4. Strategic Initiatives
  • 11.4.8. Bio-Techne Corporation
    • 11.4.8.1. Overview
    • 11.4.8.2. Financial Performance
    • 11.4.8.3. Product Benchmarking
    • 11.4.8.4. Strategic Initiatives
  • 11.4.9. Proteintech Group, Inc.
    • 11.4.9.1. Overview
    • 11.4.9.2. Financial Performance
    • 11.4.9.3. Product Benchmarking
    • 11.4.9.4. Strategic Initiatives
  • 11.4.10. Jackson ImmunoResearch Inc
    • 11.4.10.1. Overview
    • 11.4.10.2. Financial Performance
    • 11.4.10.3. Product Benchmarking
    • 11.4.10.4. Strategic Initiatives